180 related articles for article (PubMed ID: 16220297)
1. Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Virchows Arch; 2006 Jan; 448(1):68-74. PubMed ID: 16220297
[TBL] [Abstract][Full Text] [Related]
2. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
Straume O; Akslen LA
Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
[TBL] [Abstract][Full Text] [Related]
3. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
4. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor and fibroblast growth factor receptor-i in human meningiomas.
Yi W; Chen J; Golwa FH; Xue D
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):75-7. PubMed ID: 15934314
[TBL] [Abstract][Full Text] [Related]
6. Vascular proliferation is important for clinical progress of endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
Cancer Res; 2006 Mar; 66(6):3303-9. PubMed ID: 16540684
[TBL] [Abstract][Full Text] [Related]
7. Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer.
Trojan L; Thomas D; Knoll T; Grobholz R; Alken P; Michel MS
Urol Res; 2004 May; 32(2):97-103. PubMed ID: 15250102
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of aFGF and FGFR-1 is predictive of a poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura K; Ozawa S; Kitagawa Y; Ueda M; Kitajima M
Oncol Rep; 2007 Mar; 17(3):557-64. PubMed ID: 17273733
[TBL] [Abstract][Full Text] [Related]
10. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression.
Guddo F; Fontanini G; Reina C; Vignola AM; Angeletti A; Bonsignore G
Hum Pathol; 1999 Jul; 30(7):788-94. PubMed ID: 10414497
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.
Smith K; Fox SB; Whitehouse R; Taylor M; Greenall M; Clarke J; Harris AL
Ann Oncol; 1999 Jun; 10(6):707-13. PubMed ID: 10442194
[TBL] [Abstract][Full Text] [Related]
12. Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma.
Fujisawa H; Koide N; Kono T; Takayama K; Tsukioka K; Wada Y; Zhang T; Kitahara H; Nakano H; Suzuki JI; Isobe M; Amano J
J Cardiovasc Surg (Torino); 2002 Oct; 43(5):589-94. PubMed ID: 12386568
[TBL] [Abstract][Full Text] [Related]
13. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
[TBL] [Abstract][Full Text] [Related]
14. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers.
Takanami I; Tanaka F; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
Eur J Cancer; 1996 Aug; 32A(9):1504-9. PubMed ID: 8911109
[TBL] [Abstract][Full Text] [Related]
15. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
16. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
[TBL] [Abstract][Full Text] [Related]
19. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
[TBL] [Abstract][Full Text] [Related]
20. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
